Cargando…
Do No Harm: Reaffirming the Value of Evidence and Equipoise While Minimizing Cognitive Bias in the Coronavirus Disease 2019 Era
Autores principales: | Ramnath, Venktesh R., McSharry, David G., Malhotra, Atul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833575/ https://www.ncbi.nlm.nih.gov/pubmed/32473949 http://dx.doi.org/10.1016/j.chest.2020.05.548 |
Ejemplares similares
-
What Counts as “Good” Clinical Communication in the Coronavirus Disease 2019 Era and Beyond?: Ditching Checklists for Juggling Communication Goals
por: Scott, Allison M., et al.
Publicado: (2020) -
Humanizing ICU Coronavirus Disease 2019 Care
por: Marin-Corral, Judith, et al.
Publicado: (2021) -
Why Is Modeling Coronavirus Disease 2019 So Difficult?
por: Subramanian, Vigneshwar, et al.
Publicado: (2020) -
Addressing the “What do we have to lose? Just give the drug” rationale: making the case for clinical trials and against off-label use in COVID-19
por: Ramnath, Venktesh R., et al.
Publicado: (2020) -
A surplus of positive trials: weighing biases and reconsidering equipoise
por: Felson, David T, et al.
Publicado: (2004)